Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$175M |
| 2 |
Parker-Hannifin
PH
|
+$161M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$149M |
| 4 |
McDonald's
MCD
|
+$138M |
| 5 |
Bank of America
BAC
|
+$135M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
American Express
AXP
|
+$253M |
| 2 |
Meta Platforms (Facebook)
META
|
+$193M |
| 3 |
Lowe's Companies
LOW
|
+$193M |
| 4 |
CME Group
CME
|
+$179M |
| 5 |
Apple
AAPL
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 20.85% |
| 2 | Consumer Discretionary | 12.64% |
| 3 | Healthcare | 10.98% |
| 4 | Real Estate | 6.88% |
| 5 | Industrials | 6.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HEP
926
DELISTED
Holly Energy Partners, L.P.
HEP
| $4.06M | 0.01% |
125,000
+45,000
| +56% | +$1.5M |
|
|
WRK
927
DELISTED
WestRock Company
WRK
| $4.03M | 0.01% |
63,672
+12,674
| +25% | +$770K |
|
928
TSMC
TSM
$2.16T
| $4.02M | 0.01% |
+101,410
| New | +$4.11M |
|
|
LHO
929
DELISTED
LaSalle Hotel Properties
LHO
| $4.01M | 0.01% |
+142,840
| New | +$4.09M |
|
930
CALL
Vertex Pharmaceuticals
VRTX
$140B
| $4M | 0.01% |
+26,700
| New | +$3.95M |
|
931
Agnico Eagle Mines
AEM
$113B
| $3.99M | 0.01% |
+86,452
| New | +$3.86M |
|
|
CERN
932
DELISTED
Cerner Corp
CERN
| $3.98M | 0.01% |
+58,984
| New | +$4.08M |
|
933
Southwest Airlines
LUV
$20B
| $3.97M | 0.01% |
60,631
+2,620
| +5% | +$154K |
|
934
Broadridge
BR
$21.1B
| $3.95M | 0.01% |
+43,579
| New | +$3.8M |
|
|
APC
935
DELISTED
Anadarko Petroleum
APC
| $3.94M | 0.01% |
73,361
+52,301
| +248% | +$2.57M |
|
936
PUT
Encompass Health
EHC
$11.9B
| $3.92M | 0.01% |
+99,806
| New | +$3.8M |
|
937
Yum! Brands
YUM
$42.6B
| $3.92M | 0.01% |
47,985
+33,828
| +239% | +$2.68M |
|
938
PUT
McKesson
MCK
$106B
| $3.9M | 0.01% |
+25,000
| New | +$3.7M |
|
|
SAFE
939
DELISTED
Safehold Inc.
SAFE
| $3.9M | 0.01% |
221,472
+47,654
| +27% | +$865K |
|
|
PPL
940
PPL Corp
PPL
$26.3B
| $3.88M | 0.01% |
125,524
+72,166
| +135% | +$2.59M |
|
941
CALL
Williams-Sonoma
WSM
$27.6B
| $3.88M | 0.01% |
150,000
-50,000
| -25% | -$1.27M |
|
942
Bank of Montreal
BMO
$121B
| $3.86M | 0.01% |
+48,236
| New | +$3.76M |
|
|
DF
943
DELISTED
Dean Foods Company
DF
| $3.85M | 0.01% |
332,763
+295,912
| +803% | +$3.14M |
|
944
PUT
IBM
IBM
$221B
| $3.84M | 0.01% |
+26,150
| New | +$3.8M |
|
|
KA
945
DELISTED
Kineta, Inc. Common Stock
KA
| $3.83M | 0.01% |
+4,696
| New | +$1.8M |
|
946
United Airlines
UAL
$38.1B
| $3.81M | 0.01% |
56,488
-130,768
| -70% | -$8.15M |
|
947
Globus Medical
GMED
$11.1B
| $3.78M | 0.01% |
91,948
+80,074
| +674% | +$2.8M |
|
948
Acuity Brands
AYI
$10.2B
| $3.77M | 0.01% |
21,411
+16,710
| +355% | +$2.78M |
|
|
SGYP
949
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
| $3.73M | 0.01% |
1,675,000
+291,600
| +21% | +$725K |
|
950
Akamai
AKAM
$15.2B
| $3.73M | 0.01% |
+57,269
| New | +$3.17M |
|
Similar funds
Dmitry Balyasny's Q4 2017 Portfolio in Review
As of Q4 2017, Dmitry Balyasny held 2,554 positions worth $32B, up 25% from $25.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Dmitry Balyasny deployed $4.77B of net new capital in Q4 2017, opening 720 new positions and adding to 686 existing holdings. Its largest new stake was iShares iBoxx $ High Yield Corporate Bond ETF: 1,700,000 shares worth $148M.
By sector, the portfolio is most concentrated in Financials at 21% of assets, up from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was American Express, an estimated $253M trimmed.
- Dmitry Balyasny's largest Q4 2017 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 1,700,000 shares worth $148M.
- Dmitry Balyasny added most to Aetna Inc in Q4 2017, an estimated $175M increase.
- Dmitry Balyasny's biggest Q4 2017 reduction was American Express, cutting an estimated $253M.
- Dmitry Balyasny fully exited Range Resources in Q4 2017, selling an estimated $104M.
- Dmitry Balyasny's ten largest holdings make up 11% of its $32B portfolio in Q4 2017.
- Dmitry Balyasny opened 720 new positions and closed 529 in Q4 2017.
- Dmitry Balyasny's portfolio value rose 25% quarter-over-quarter to $32B.
Based on Balyasny Asset Management's 13F filing for Q4 2017, filed 14 Feb 2018.